etira
  • Home
  • Our Company
  • Our Science
  • Clinical Trial
  • Our Pipeline
  • Our Team
  • News
  • Contact
  • Menu Menu
  • LinkedIn
  • Home
  • Our Company
  • Our Science
  • Clinical Trial
  • Our Pipeline
  • Our Team
  • News
  • Contact

Connect with us Whether you are interested in learning more about Etira, or joining our team to help us defeat cancer, fill out the form below and let’s get connected.

Contact

Office Address:

EtiraRx Inc
3033 Irving Blvd
Dallas. TX. 75247

Mailing Address:

EtiraRx Inc
3060 Pegasus Park Dr.
Dallas. TX. 75247

WANT TO STAY IN THE LOOP?
Join Our List Of Interested Parties

We value your privacy. We never send you any spam or pass your information to 3rd parties.

 

etira logo

 

Where to find us

Dallas Office:
3033 Irving Blvd,
Dallas. TX. 75247

Mailing Address:
3060 Pegasus Park Dr.
Dallas. TX. 75247

Scroll to top
Inclusion criteria:
  • Patients must be at least 18 years of age at the time of signing the informed consent.
  • Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1.
  • Patients must have histologically or cytologically confirmed solid tumor, primarily including but not limited to breast, ovarian, pancreatic, endometrial, and hepatocellular carcinoma, that is advanced unresectable and/or metastatic disease for whom standard therapies do not exist or are no longer effective
  • Patients must have measurable disease as per Response Evaluation Criteria in Solid Tumors (RECIST) v1.1.
  • Adequate baseline organ function and hematologic function
  • Life expectancy >3 months
Exclusion criteria
  • Systemic anti-cancer therapy within 4 weeks of first dose of study drug
  • Major surgery (as defined by the Investigator) within 4 weeks of first dose of study drug.
  • Uncontrolled intercurrent illnesses
  • Known history of LIPA deficiency, such as Wolman disease or Cholesterol ester storage disease.